JACC Journals and the American College of Cardiology highlight blood pressure guideline discussion and evidence for Baduanjin lowering systolic blood pressure with sustained effects, positioning lifestyle and guideline updates as ongoing priorities.
2025 AHA/ACC High Blood Pressure Guideline
Baduanjin lowered systolic #bloodpressure (BP)
sustained BP-lowering effect until 1 year
comparable efficacy to brisk walking
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare